SFRP5 and metabolic dysfunction-associated steatotic liver disease: To further investigate the possible relationships between NAFLD-related to obesity and SFRP5, WNT5A or PPARγ adipose tissue expression, associations have been analyzed with circulating cytokines, as shown in Table 2.